Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Miklos RohlaThomas W WeissLadislav PecenGiuseppe PattiJolanta M Siller-MatulaRenate B SchnabelRichard SchillingDipak KotechaMarkus LucernaKurt HuberRaffaele De CaterinaPaulus F KirchhofPublished in: BMJ open (2019)
Attending to modifiable risk factors is an important treatment target in anticoagulated AF patients to reduce thromboembolic and bleeding events. Initiation of anticoagulation in those at risk of stroke should not be prevented by elevated bleeding risk scores.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- risk factors
- end stage renal disease
- heart failure
- percutaneous coronary intervention
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cross sectional
- study protocol
- acute coronary syndrome
- blood brain barrier
- replacement therapy